Location History:
- Cologne, DE (2020)
- Bergisch Gladbach, DE (2019 - 2024)
Company Filing History:
6 out of 41 
1 out of 58 
1 out of 1 Years Active: 2019-2025
Title: **Innovative Breakthroughs by Inventor Anne Richter**
Introduction
Anne Richter, a distinguished inventor based in Bergisch Gladbach, Germany, has made significant contributions to the field of immunotherapy. With a portfolio of seven patents, her work is primarily focused on reducing the side effects associated with immunotherapy treatments. Her innovative approaches have the potential to transform patient experiences in cancer treatments, particularly those involving CAR T cell therapy.
Latest Patents
Among her most recent patents, Anne Richter has developed a system aimed at preventing or reducing the side effects in patients undergoing immunotherapy. One of her notable inventions involves genetically modified hematopoietic cells. This process entails obtaining healthy hematopoietic cells from the patient or a donor, subsequently engineering them to either not express a target antigen, express it at a lower density, or modify its form. Upon administration, these engineered cells help restore hematopoietic cell function, thus minimizing adverse side effects during treatment.
Additionally, she has devised a system that enhances the effectiveness of immunotherapy for cancer patients using CAR T or CAR NK cells. This innovation incorporates pharmaceutical agents that help reduce side effects caused by antigen-recognizing receptors, particularly in cases where hematopoietic cells are present. By utilizing an antigen-recognizing receptor that specifically targets antigens on cells, diagnosed individuals can receive treatment that acknowledges both efficiency and safety.
Career Highlights
Anne Richter's career is marked by her association with prominent companies such as Miltenyi Biotec B.V. & Co. KG and Miltenyi Biotec GmbH. Her work in these organizations has allowed her to delve deeper into the realm of immunotherapy, fostering developments that bridge scientific research and practical medical applications.
Collaborations
Collaborating with notable professionals in the field, including Mario Assenmacher and Stefan Miltenyi, has played a pivotal role in her innovative journey. These partnerships have not only enriched her research but have also contributed to the successful implementation of her inventions in clinical settings.
Conclusion
Anne Richter stands out as a pioneering inventor whose work is redefining cancer treatment approaches. Through her relentless efforts and innovative mindset, she contributes significantly to improving patient outcomes in immunotherapy. Her patents illustrate the power of creativity and collaboration in science, promising a brighter future for countless patients battling cancer.